Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

Verizon Communications Inc

Change company Symbol lookup

Select an option...

VZ Verizon Communications Inc

CETX Cemtrex Inc

RNXT RenovoRx Inc

BNTX BioNTech SE

ARTW Art's Way Manufacturing Co Inc

ARIZU Arisz Acquisition Corp

OSH Oak Street Health Inc

LESL Leslie's Inc

AAPL Apple Inc

BYM BlackRock Municipal Income Quality Trust

Communication Services : Diversified Telecommunication Services | Large Cap Value

Company profile

Verizon Communications Inc. is a holding company. The Company, through its subsidiaries, provides communications, information and entertainment products and services to consumers, businesses, and governmental agencies. Its reportable segments are Verizon Consumer Group and Verizon Business Group. Its Consumer segment provides wireless and wireline communications services. Its wireless services are provided across wireless networks in the United States (U.S.) under the Verizon brand. Its wireline services are provided in nine states in the Mid-Atlantic and Northeastern U.S., as well as Washington D.C., over its fiber-optic network under the Fios brand and over a traditional copper-based network. Its Business segment provides wireless and wireline communications services and products, including data, video and conferencing services, security and managed network services, local and long-distance voice services and network access to deliver various Internet of Things services and products.

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

4:41 pm ET January 26, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) slipped 0.25% to $72.99 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.10% to 4,060.43 and the Dow Jones Industrial Average rising 0.61% to 33,949.41. Bristol Myers Squibb Co. closed $8.45 short of its 52-week high ($81.44), which the company achieved on December 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.37% to $168.89, Pfizer Inc. (PFE) fell 0.92% to $44.25, and Abbott Laboratories (ABT) rose 0.06% to $111.07. Trading volume (6.5 M) remained 2.5 million below its 50-day average volume of 9.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 26, 2023.

(END) Dow Jones Newswires

January 26, 2023 16:41 ET (21:41 GMT)

Premarket

Change Since Close

Market Hours

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day